Selective immunodepression.
D000818:Animals; D000906:Antibodies / Q000276:immunology; D000915:Antibody Affinity; D000917:Antibody Formation / Q000187:drug effects; D000918:Antibody Specificity; D000937:Antigen-Antibody Reactions; D000941:Antigens / Q000008:administration & dosage; D000961:Antilymphocyte Serum / Q000494:pharmacology; D001402:B-Lymphocytes / Q000276:immunology; D001666:Binding Sites, Antibody; D001667:Binding, Competitive; D002455:Cell Division / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D000939:Epitopes; D006168:Guinea Pigs; D007108:Immune Tolerance; D007114:Immunization; D007116:Immunization, Passive; D007136:Immunoglobulins / Q000276:immunology; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000494:pharmacology; D013601:T-Lymphocytes / Q000276:immunology
D000906:Antibodies; D000941:Antigens; D000961:Antilymphocyte Serum; D000939:Epitopes; D007136:Immunoglobulins; D007166:Immunosuppressive Agents